Electrosurgical device with internal digestor electrode

Information

  • Patent Grant
  • 9011428
  • Patent Number
    9,011,428
  • Date Filed
    Thursday, March 1, 2012
    13 years ago
  • Date Issued
    Tuesday, April 21, 2015
    10 years ago
Abstract
An electrosurgical wand is described, for treating a target tissue using electrosurgical energy, which has an elongate shaft with a handle end and a distal end. A first active electrode surface is disposed on the distal end of the shaft and a first digester electrode surface is recessed away from the first active electrode surface and electrically connected with the first active electrode surface. An aspiration aperture is also disposed adjacent the first active electrode surface and fluidly connected with an aspiration lumen, wherein the first digester electrode surface is disposed within the aspiration lumen.
Description
FIELD OF THE INVENTION

This invention relates generally to methods and apparatus for accessing and treating tissue, and more particularly to apparatus and methods for electrosurgically treating tissue such as laryngeal tissue.


BACKGROUND

The field of electrosurgery includes a number of loosely related surgical techniques which have in common the application of electrical energy to modify the structure or integrity of patient tissue. Electrosurgical procedures usually operate through the application of very high frequency currents to cut or ablate tissue structures, where the operation can be monopolar or bipolar. Monopolar techniques rely on a separate electrode for the return of current that is placed away from the surgical site on the body of the patient, and where the surgical device defines only a single electrode pole that provides the surgical effect. Bipolar devices comprise two or more electrodes on the same support for the application of current between their surfaces.


Electrosurgical procedures and techniques are particularly advantageous because they generally reduce patient bleeding and trauma associated with cutting operations. Additionally, electrosurgical ablation procedures, where tissue surfaces and volume may be reshaped, cannot be duplicated through other treatment modalities.


Radiofrequency (RF) energy is used in a wide range of surgical procedures because it provides efficient tissue resection and coagulation and relatively easy access to the target tissues through a portal or cannula. Conventional monopolar high frequency electrosurgical devices typically operate by creating a voltage difference between the active electrode and the target tissue, causing an electrical arc to form across the physical gap between the electrode and tissue. At the point of contact of the electric arcs with tissue, rapid tissue heating occurs due to high current density between the electrode and tissue. This high current density causes cellular fluids to rapidly vaporize into steam, thereby producing a “cutting effect” along the pathway of localized tissue heating. Thus, the tissue is parted along the pathway of evaporated cellular fluid, inducing undesirable collateral tissue damage in regions surrounding the target tissue site. This collateral tissue damage often causes indiscriminate destruction of tissue, resulting in the loss of the proper function of the tissue. In addition, the device does not remove any tissue directly, but rather depends on destroying a zone of tissue and allowing the body to eventually remove the destroyed tissue.


Present electrosurgical devices used for tissue ablation in narrow anatomies may suffer from concerns associated with the difficulties that the device size may present in accessing certain treatment areas. Specifically, instances may arise where the device may have a shaft diameter that is too wide or shaft working length that is not sufficiently long making the desired access problematic. In additional, present devices used for tissue removal may suffer from poor visibility at the working end of the device where the overall size or orientation of the device tip obscures the physician's view of the surgical field. The inability to easily access and visualize the surgical field is a significant disadvantage in using electrosurgical techniques for tissue ablation, particularly in arthroscopic, otolaryngological, and spinal procedures.


Alternative devices for tissue treatment in narrow anatomies, such as CO2 lasers or microdebriders, may suffer from additional shortcomings in addition to obstacles attributed to the size of the device. For example, a CO2 laser may require a substantially longer set up time prior to the actual procedure, and such lasers are further impaired by relatively smaller tissue removal rate and increased collateral damage to tissue. Microdebriders typically are not afforded adequate hemostatis capabilities, resulting in the presence of significant amounts of blood likely contributing to blocked visibility of the surgical field and prolonged procedure times as other materials are required to stop bleeding.


Accordingly, improved systems and methods are still desired for precise tissue removal in narrow anatomies via electrosurgical ablation of tissue. In particular, improved systems operable designed to provide access to narrow anatomies while allowing increased surgical field visualization would provide a competitive advantage.





BRIEF DESCRIPTION OF THE DRAWINGS

For a detailed description of exemplary embodiments, reference will now be made to the accompanying drawings in which:



FIG. 1 shows an electrosurgical system in accordance with at least some embodiments;



FIG. 2 shows an end elevation view of a wand in accordance with at least some embodiments;



FIG. 3 shows a cross-sectional view of a wand distal end in accordance with at least some embodiments;



FIG. 4 shows a cross-sectional view of a wand in accordance with at least some embodiments;



FIG. 5 shows an overhead view of a wand in accordance with at least some embodiments;



FIG. 6A shows a cross-sectional view of a wand connector in accordance with at least some embodiments;



FIG. 6B shows an elevational end-view of a wand connector in accordance with at least some embodiments;



FIG. 7A shows a cross-sectional view of a controller connector in accordance with at least some embodiments;



FIG. 7B shows both an elevational end-view of a controller connector in accordance with at least some embodiments;



FIG. 8 shows an electrical block diagram of an electrosurgical controller in accordance with at least some embodiments; and



FIG. 9 shows a method in accordance with at least some embodiments.





NOTATION AND NOMENCLATURE

Certain terms are used throughout the following description and claims to refer to particular system components. As one skilled in the art will appreciate, companies that design and manufacture electrosurgical systems may refer to a component by different names. This document does not intend to distinguish between components that differ in name but not function.


In the following discussion and in the claims, the terms “including” and “comprising” are used in an open-ended fashion, and thus should be interpreted to mean “including, but not limited to . . . .” Also, the term “couple” or “couples” is intended to mean either an indirect or direct connection. Thus, if a first device couples to a second device, that connection may be through a direct connection or through an indirect electrical connection via other devices and connections.


Reference to a singular item includes the possibility that there are plural of the same items present. More specifically, as used herein and in the appended claims, the singular forms “a,” “an,” “said” and “the” include plural references unless the context clearly dictates otherwise. It is further noted that the claims may be drafted to exclude any optional element. As such, this statement serves as antecedent basis for use of such exclusive terminology as “solely,” “only” and the like in connection with the recitation of claim elements, or use of a “negative” limitation. Lastly, it is to be appreciated that unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.


“Active electrode” shall mean an electrode of an electrosurgical wand which produces an electrically-induced tissue-altering effect when brought into contact with, or close proximity to, a tissue targeted for treatment.


“Return electrode” shall mean an electrode of an electrosurgical wand which serves to provide a current flow path for electrons with respect to an active electrode, and/or an electrode of an electrical surgical wand which does not itself produce an electrically-induced tissue-altering effect on tissue targeted for treatment.


“Digester electrode” or “digester surface” shall mean an electrode or a discrete, electrically connected portion of an active electrode of an electrosurgical wand which serves to produce an additional electrically-induced tissue-altering effect when brought into contact with, or close proximity to by-products or tissue remnants produced by the active electrode.


A fluid conduit said to be “within” an elongate shaft shall include not only a separate fluid conduit that physically resides within an internal volume of the elongate shaft, but also situations where the internal volume of the elongate shaft is itself the fluid conduit.


Where a range of values is provided, it is understood that every intervening value, between the upper and lower limit of that range and any other stated or intervening value in that stated range is encompassed within the invention. Also, it is contemplated that any optional feature of the inventive variations described may be set forth and claimed independently, or in combination with any one or more of the features described herein.


All existing subject matter mentioned herein (e.g., publications, patents, patent applications and hardware) is incorporated by reference herein in its entirety except insofar as the subject matter may conflict with that of the present invention (in which case what is present herein shall prevail). The referenced items are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present invention is not entitled to antedate such material by virtue of prior invention.


DETAILED DESCRIPTION

Before the various embodiments are described in detail, it is to be understood that this invention is not limited to particular variations set forth herein as various changes or modifications may be made, and equivalents may be substituted, without departing from the spirit and scope of the invention. As will be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present invention. In addition, many modifications may be made to adapt a particular situation, material, composition of matter, process, process act(s) or step(s) to the objective(s), spirit or scope of the present invention. All such modifications are intended to be within the scope of the claims made herein.



FIG. 1 illustrates an electrosurgical system 100 in accordance with at least some embodiments. In particular, the electrosurgical system comprises an electrosurgical wand 102 (hereinafter “wand”) coupled to an electrosurgical controller 104 (hereinafter “controller”). The wand 102 comprises an elongate shaft 106 that defines distal end 108 where at least some electrodes are disposed. The elongate shaft 106 further defines a handle or proximal end 110, where a physician grips the wand 102 during surgical procedures. The wand 102 further comprises a flexible multi-conductor cable 112 housing a plurality of electrical leads (not specifically shown in FIG. 1), and the flexible multi-conductor cable 112 terminates in a wand connector 114. As shown in FIG. 1, the wand 102 couples to the controller 104, such as by a controller connector 120 on an outer surface 122 (in the illustrative case of FIG. 1, the front surface).


Though not visible in the view of FIG. 1, in some embodiments the wand 102 has one or more internal fluid conduits coupled to externally accessible tubular members. As illustrated, the wand 102 has a flexible tubular member 116 and a second flexible tubular member 118. In some embodiments, the flexible tubular member 116 is used to provide electrically conductive fluid (e.g., saline) to the distal end 108 of the wand. Likewise in some embodiments, flexible tubular member 118 is used to provide aspiration to the distal end 108 of the wand.


Still referring to FIG. 1, a display device or interface panel 124 is visible through the outer surface 122 of the controller 104, and in some embodiments a user may select operational modes of the controller 104 by way of the interface device 124 and related buttons 126.


In some embodiments the electrosurgical system 100 also comprises a foot pedal assembly 130. The foot pedal assembly 130 may comprise one or more pedal devices 132 and 134, a flexible multi-conductor cable 136 and a pedal connector 138. While only two pedal devices 132, 134 are shown, one or more pedal devices may be implemented. The outer surface 122 of the controller 104 may comprise a corresponding connector 140 that couples to the pedal connector 138. A physician may use the foot pedal assembly 130 to control various aspects of the controller 104, such as the operational mode. For example, a pedal device, such as pedal device 132, may be used for on-off control of the application of radio frequency (RF) energy to the wand 102, and more specifically for control of energy in an ablation mode. A second pedal device, such as pedal device 134, may be used to control and/or set the operational mode of the electrosurgical system. For example, actuation of pedal device 134 may switch between energy levels of an ablation mode.


The electrosurgical system 100 of the various embodiments may have a variety of operational modes. One such mode employs Coblation® technology. In particular, the assignee of the present disclosure is the owner of Coblation technology. Coblation technology involves the application of a radio frequency (RF) signal between one or more active electrodes and one or more return electrodes of the wand 102 to develop high electric field intensities in the vicinity of the target tissue. The electric field intensities may be sufficient to vaporize an electrically conductive fluid over at least a portion of the one or more active electrodes in the region between the one or more active electrodes and the target tissue. The electrically conductive fluid may be inherently present in the body, such as blood, or in some cases extracellular or intracellular fluid. In other embodiments, the electrically conductive fluid may be a liquid or gas, such as isotonic saline. In some embodiments, such as surgical procedures on a disc between vertebrae, the electrically conductive fluid is delivered in the vicinity of the active electrode and/or to the target site by the wand 102, such as by way of the internal passage and flexible tubular member 116.


When the electrically conductive fluid is heated to the point that the atoms of the fluid vaporize faster than the atoms re-condense, a gas is formed. When sufficient energy is applied to the gas, the atoms collide with each other causing a release of electrons in the process, and an ionized gas or plasma is formed (the so-called “fourth state of matter”). Stated otherwise, plasmas may be formed by heating a gas and ionizing the gas by driving an electric current through the gas, or by directing electromagnetic waves into the gas. The methods of plasma formation give energy to free electrons in the plasma directly, electron-atom collisions liberate more electrons, and the process cascades until the desired degree of ionization is achieved. A more complete description of plasma can be found in Plasma Physics, by R. J. Goldston and P. H. Rutherford of the Plasma Physics Laboratory of Princeton University (1995), the complete disclosure of which is incorporated herein by reference.


As the density of the plasma becomes sufficiently low (i.e., less than approximately 1020 atoms/cm3 for aqueous solutions), the electron mean free path increases such that subsequently injected electrons cause impact ionization within the plasma. When the ionic particles in the plasma layer have sufficient energy (e.g., 3.5 electron-Volt (eV) to 5 eV), collisions of the ionic particles with molecules that make up the target tissue break molecular bonds of the target tissue, dissociating molecules into free radicals which then combine into gaseous or liquid species. Often, the electrons in the plasma carry the electrical current or absorb the electromagnetic waves and, therefore, are hotter than the ionic particles. Thus, the electrons, which are carried away from the target tissue toward the active or return electrodes, carry most of the plasma's heat, enabling the ionic particles to break apart the target tissue molecules in a substantially non-thermal manner.


By means of the molecular dissociation (as opposed to thermal evaporation or carbonization), the target tissue is volumetrically removed through molecular dissociation of larger organic molecules into smaller molecules and/or atoms, such as hydrogen, oxygen, oxides of carbon, hydrocarbons and nitrogen compounds. The molecular dissociation completely removes the tissue structure, as opposed to dehydrating the tissue material by the removal of liquid within the cells of the tissue and extracellular fluids, as occurs in related art electrosurgical desiccation and vaporization. A more detailed description of the molecular dissociation can be found in commonly assigned U.S. Pat. No. 5,697,882, the complete disclosure of which is incorporated herein by reference.


In addition to the Coblation mode, the electrosurgical system 100 of FIG. 1 may also in particular situations be useful for sealing larger arterial vessels (e.g., on the order of about 1 mm in diameter), when used in what is known as a coagulation mode. Thus, the system of FIG. 1 may have an ablation mode where RF energy at a first voltage is applied to one or more active electrodes sufficient to effect molecular dissociation or disintegration of the tissue, and the system of FIG. 1 may have a coagulation mode where RF energy at a second, lower voltage is applied to one or more active electrodes (either the same or different electrode(s) as the ablation mode) sufficient to heat, shrink, seal, fuse, and/or achieve homeostasis of severed vessels within the tissue.


The energy density produced by electrosurgical system 100 at the distal end 108 of the wand 102 may be varied by adjusting a variety of factors, such as: the number of active electrodes; electrode size and spacing; electrode surface area; asperities and/or sharp edges on the electrode surfaces; electrode materials; applied voltage; current limiting of one or more electrodes (e.g., by placing an inductor in series with an electrode); electrical conductivity of the fluid in contact with the electrodes; density of the conductive fluid; and other factors. Accordingly, these factors can be manipulated to control the energy level of the excited electrons. Because different tissue structures have different molecular bonds, the electrosurgical system 100 may be configured to produce energy sufficient to break the molecular bonds of certain tissue but insufficient to break the molecular bonds of other tissue. For example, fatty tissue (e.g., adipose) has double bonds that require an energy level higher than 4 eV to 5 eV (i.e., on the order of about 8 eV) to break. Accordingly, the Coblation® technology in some operational modes does not ablate such fatty tissue; however, the Coblation® technology at the lower energy levels may be used to effectively ablate cells to release the inner fat content in a liquid form. Other modes may have increased energy such that the double bonds can also be broken in a similar fashion as the single bonds (e.g., increasing voltage or changing the electrode configuration to increase the current density at the electrodes).


A more complete description of the various phenomena can be found in commonly assigned U.S. Pat. Nos. 6,355,032; 6,149,120 and 6,296,136, the complete disclosures of which are incorporated herein by reference.



FIG. 2 illustrates an end elevation view of the distal end 108 of wand 102 in accordance with at least some embodiments. In some embodiments, a portion of the elongate shaft 106 may be made of a metallic material (e.g., Grade TP304 stainless steel hypodermic tubing). In other embodiments, portions of the elongate shaft may be constructed of other suitable materials, such as inorganic insulating materials. The elongate shaft 106 may define a circular cross-section at the handle or proximal end 110 (not shown in FIG. 2), and at least a portion of the distal end 108 may also be circular in cross-section. For wands intended for use in otolaryngological procedures, and in particular for use in procedures where access to the larynx is desired, the diameter of shaft 106 may be 3 centimeters or less, and in some cases 2.8 millimeters. Additionally, the length of shaft 106 from handle 110 to the tip of distal end 108 may be 8.5 inches, and in some cases 7.5 inches. Other dimensions may be equivalently used when the surgical procedure allows.


In embodiments where the elongate shaft is metallic, the distal end 108 may further comprise a non-conductive spacer 200 coupled to the elongate shaft 106. In some cases the spacer 200 is ceramic, but other non-conductive materials resistant to degradation when exposed to plasma may be equivalently used (e.g., glass). The spacer 200 supports electrodes of conductive material, with illustrative active electrode labeled 202 in FIG. 2. Active electrode 202 defines an exposed surface area of conductive material, where active electrode 202 is a loop of wire of particular diameter. For embodiments using a loop of wire, the loop of wire may be molybdenum or tungsten having a diameter between and including 0.008 and 0.015 inches, and more preferably of 0.010 inches. In certain embodiments, the active electrode 202 has an exposed ablative surface 203 bridging aspiration aperture 207 wherein exposed surface 203 defines a straight portion of active electrode 202 that is oriented substantially parallel to the long axis of distal end 108.


In certain embodiments electrode 202 has an active electrode recessed secondary surface 210 that may be oriented substantially transverse to the long axis of the distal end 108 and may be recessed within the spacer 200, so that the surface 210 is disposed below a top surface 220 of the spacer 200. Secondary surface 210 may be recessed within an elongate nest provided by spacer 200, the nest being deep enough so that the secondary 210 may not treat tissue inadvertently, however is capable of applying energy to a target tissue, should the surgeon intentionally oppose this surface 210 against tissue so that the tissue extends into the recesses area around secondary electrode surface 210. Is alternative embodiments, this surface 210 may be insulated so as to not be an active surface (not shown here).


Referring still to FIG. 2, wand 102 includes a return electrode 204 for completing the current path between active electrode 202 and controller 104 (not shown in this figure). Return electrode 204 is suitably connected to controller 104. Return electrode 204 is preferably a semi-annular member defining the exterior of shaft 106, and a distal portion of return electrode 204 on the side of shaft 106 corresponding to the exposed surface 203 of active electrode 202 is preferably exposed (e.g., approximately half the circumference of return electrode 204 is exposed and free of insulative covering). Additionally, a section of the distal portion of return electrode 204 may be disposed within sheath 209, preferably the section disposed on the opposite side of shaft 106 from exposed surface 203 of active electrode 202. At least a proximal portion of return electrode 204 is disposed within an electrically insulative sheath 209, which is typically formed as one, or more electrically insulative sheaths or coatings, such as polytetrafluoroethylene, polyimide, and the like. The provision of the electrically insulative sheath 209 encircling over a portion of return electrode 204 may minimize prevents direct electrical contact between return electrode 204 and any adjacent body structure or the surgeon. Such direct electrical contact between a body structure (e.g., tendon) and an exposed common electrode member 204 could result in unwanted heating and necrosis of the structure at the point of contact causing necrosis. Return electrode 204 is preferably formed from an electrically conductive material, usually metal, which is selected from the group consisting of stainless steel alloys, platinum or its alloys, titanium or its alloys, molybdenum or its alloys, and nickel or its alloys.


In some embodiments saline is delivered to the distal end 108 of wand, possibly to aid in plasma creation. Referring still to FIG. 2, discharge aperture 208 is illustrated on the distal end 108 disposed through return electrode 204. Discharge aperture 208 is formed through the exposed portion of return electrode 204 on the same side of shaft 106 as exposed surface 203 of active electrode 202. It is preferable that discharge aperture 208 is disposed proximally of aspiration aperture 207 and the exposed surface 203 of active electrode 202. The discharge aperture 208 is fluidly coupled to the flexible tubular member 116 (FIG. 1) by way of a fluid conduit within the wand 102. Thus, saline or other fluid may be pumped into the flexible tubular member 116 (FIG. 1) and discharged through discharge aperture 208 to further aid in developing consistent wetting around the exposed surface or circumference of return electrode 204. Discharge aperture 208 is disposed towards the proximal end of return electrode 204, so that a large portion of the return electrode surface area is sufficiently wetted, as the fluid travels from the discharge aperture 208 towards the exposed surface 203. Discharge aperture 208 is approximately crescent or boomerang shaped with the widest portion or widest opening, as measured parallel to distal end long axis, substantially in line with active surface 203. This aperture 208 shape has been found to produce a preferable uniform and directed flow, distally, over the return electrode surface and towards the active electrode 202.


In yet still further embodiments, aspiration is provided at the distal end 108 of the wand 102. FIGS. 2 and 3 illustrate aspiration aperture 207 (i.e., suction port 207) at the distal end 108 of the device and disposed through the non-conductive spacer 200. Suction aperture 207 is disposed at distal end 108 and in certain embodiments preferably only located on one side of spacer 200 and disposed through spacer 200 on the same side of shaft 106 as the exposed surface 203 of active electrode 202 and discharge aperture 208. More particularly, and as stated above, suction port 207 is disposed adjacent to and behind exposed surface 203 such that exposed surface 203 bridges or traverses a portion of suction port 207. Suction port 207 provides a path to aspirate the area near the distal end 108, so as to remove excess fluids, ablative by-products, and remnants of ablation created by exposed surface 203 of active electrode 202. The location of suction port 207 further provides for ample wetting of the active and return electrodes, with the saline flowing out from discharge aperture 208 and then being pulled toward active electrode 202 by the fluid flow induced from suction port 207. Applicants have found it is particularly beneficial to provide broader wetting of the exposed surface of return electrode 204, enabling more uniform plasma formation particularly on the exposed surface 203 of active electrode 202.


Referring now to FIG. 3, a cross-section of the distal tip of the wand in accordance with certain embodiments is shown. In particular, digester electrode or digester surface 205 of active electrode 202 is shown. Digester surface 205 is shown disposed within a portion of spacer 200 and located substantially within the aspiration fluid path. In particular, digester surface 205 is disposed coaxially within suction lumen 206, wherein suction lumen 206 is fluidly connected to suction port 207, and where digester surface 205 is recessed away from the opening of suction port 207. In certain embodiments, digester surface 205 is a discrete section of the loop of wire that forms active electrode 202, and digester surface 205 is thereby electrically connected to active electrode 202. Active electrode 202 may be formed in a shape resembling a hook, where exposed surface 203 forms one portion of the hook and digester surface 205 forms the opposite side of the hook, with a contiguous piece of active electrode 202 (secondary surface 210) spanning transversely to the long axis of distal end 108 and routed within a recessed portion of spacer 200. Digester surface 205 is preferably arranged parallel to and co-planar with exposed surface 203 of active electrode 202. Digester surface 205 may preferably include at least one asperity, such as a sharp edge or point, for example surface end 211, where a higher charge density will form, so that when a high frequency voltage is applied between the active electrode and return electrode, a plasma may readily initiate in the presence of an electrically conductive fluid, at this asperity, so as to further morcellate any tissue or ablation by-products that are travelling through the suction lumen 206. Fluids, ablative by-products, and tissue remnants produced by the initial tissue treatment initiated by exposed surface 203 are aspirated away from the tissue treatment site via suction port 207 and into suction lumen 206 such that the ablative by-products are exposed to the electrically-induced effects of digester electrode 205 and thereby further reduced for uninterrupted aspiration. By disposing digester surface 205 within the aspiration fluid flow path, additional ablation and breakdown of the initial ablative by-products is produced in order to minimize clogging of suction lumen 206. Suction lumen 206 is approximately perpendicular to suction port 207 and may be coaxial with the distal end long axis. A diameter of suction lumen 206 may preferably be less than a diameter of the suction port 207, so as fit within the confines of the smaller wand shaft diameter, as described earlier.


As shown for example in FIGS. 2 and 3, return electrode 204 is not directly connected to active electrode 202. To complete a current path so that active electrode 202 is electrically connected to return electrode 204 in the presence of a target tissue, electrically conducting liquid (e.g., isotonic saline) is caused to flow along liquid paths emanating from discharge aperture 208 toward and within suction port 207 and suction 206, and contacting both return electrode 204 and active electrode 202. When a voltage difference is applied between active electrode 202 and return electrode 204, high electric field intensities will be generated at active electrode 202, and particularly adjacent to exposed surface 203 and digester surface 205 of active electrode 202. As current flows from active electrode 202 to the return electrode 204 in the presence of electrically conductive fluid, the high electric field intensities cause ablation of target tissue adjacent exposed surface 203 of active electrode 202. Further ablation and breakdown of aspirated by-products from the initial ablation of the target tissue occurs adjacent digester surface 205 of active electrode 202 in order to prevent clogging of the aspiration features of the device.



FIG. 4 shows a cross-sectional elevation view of a wand 102 in accordance with at least some embodiments. In particular, FIG. 4 shows the handle or proximal end 110 coupled to the elongate shaft 106. As illustrated, the elongate shaft 106 telescopes within the handle, but other mechanisms to couple the elongate shaft to the handle may be equivalently used. The elongate shaft 106 defines internal conduit 400 that serves several purposes. For example, in the embodiments illustrated by FIG. 4 the electrical leads 402 and 404 extend through the internal conduit 400 to electrically couple to the active electrode 202 and return electrode 204, respectively. Likewise, the flexible tubular member 116 extends through the internal conduit 400 to fluidly couple to discharge aperture 208.


The internal conduit 400 also serves as the aspiration route. In particular, FIG. 4 illustrates suction port 207. In the embodiments illustrated the flexible tubular member 118, through which aspiration is performed, couples through the handle and then fluidly couples to the internal conduit 400. Thus, the suction provided through flexible tubular member 118 provides aspiration via suction lumen 206 at the suction port 207. The fluids that are drawn into the internal fluid conduit 400 may abut the portion of the flexible tubular member 116 that resides within the internal conduit as the fluids are drawn along the conduit; however, the flexible tubular member 116 is sealed, and thus the aspirated fluids do not mix with the fluid (e.g., saline) being pumped through the flexible tubular member 116. Likewise, the fluids that are drawn into the internal fluid conduit 400 may abut portions of the electrical leads 402 and 404 within the internal fluid conduit 400 as the fluids are drawn along the conduit. However, the electrical leads are insulated with an insulating material that electrically and fluidly isolates the leads from any substance within the internal fluid conduit 400. Thus, the internal fluid conduit serves, in the embodiments shown, two purposes—one to be the pathway through which the flexible tubular member 116 and electrical leads traverse to reach the distal end 108, and also as the conduit through which aspiration takes place. In other embodiments, the flexible tubular member 118 may extend partially or fully through the elongate shaft 106, and thus more directly couple to the aspiration aperture.


The offsets of the elongate shaft 106 are not visible in FIG. 4 because of the particular view; however, FIG. 5 shows illustrative offsets. FIG. 5 shows an overhead view of the wand 102 in an orientation where the offsets in the elongate shaft 106 are visible. The illustrative wand 102 is designed and constructed for use in procedures where other equipment (e.g., an arthroscopic camera or surgical microscope) may be present and where those other devices prevent use of straight elongate shaft. In particular, the distal end 108 defines wand tip axis 502, and the elongate shaft 106 also defines a medial portion 500 which has an axis 504 (hereafter, the medial axis 504). In the particular embodiments illustrated the angle α between the medial axis 504 and the wand tip axis 502 is non-zero, and in some embodiments the acute angle α between the medial axis 504 and the wand tip axis 502 is 16 degrees, but greater or lesser angles may be equivalently used.


Likewise, the elongate shaft 106 of FIG. 5 defines a proximal portion 506 with an axis 508 (hereafter, the proximal axis 508). In the particular embodiment illustrated the angle β between the proximal axis 508 and the medial axis 504 is non-zero, and in some embodiments the acute angle β between the proximal axis 508 and the medial axis 504 is 55 degrees, but greater or lesser angles may be equivalently used.


As illustrated in FIG. 1, flexible multi-conductor cable 112 (and more particularly its constituent electrical leads 402, 404 and possibly others) couple to the wand connector 114. Wand connector 114 couples the controller 104, and more particularly the controller connector 120. FIG. 6 shows both a cross-sectional view (right) and an end elevation view (left) of wand connector 114 in accordance with at least some embodiments. In particular, wand connector 114 comprises a tab 600. Tab 600 works in conjunction with a slot on controller connector 120 (shown in FIG. 7) to ensure that the wand connector 114 and controller connector 120 only couple in one relative orientation. The illustrative wand connector 114 further comprises a plurality of electrical pins 602 protruding from wand connector 114. In many cases, the electrical pins 602 are coupled one each to an electrical lead of electrical leads 604 (two of which may be leads 402 and 404 of FIG. 4). Stated otherwise, in particular embodiments each electrical pin 602 couples to a single electrical lead, and thus each illustrative electrical pin 602 couples to a single electrode of the wand 102. In other cases, a single electrical pin 602 couples to multiple electrodes on the electrosurgical wand 102. While FIG. 6 shows four illustrative electrical pins, in some embodiments as few as two electrical pins, and as many as 26 electrical pins, may be present in the wand connector 114.



FIG. 7 shows both a cross-sectional view (right) and an end elevation view (left) of controller connector 120 in accordance with at least some embodiments. In particular, controller connector 120 comprises a slot 700. Slot 700 works in conjunction with a tab 600 on wand connector 114 (shown in FIG. 5) to ensure that the wand connector 114 and controller connector 120 only couple in one orientation. The illustrative controller connector 120 further comprises a plurality of electrical pins 702 residing within respective holes of controller connector 120. The electrical pins 702 are coupled to terminals of a voltage generator within the controller 104 (discussed more thoroughly below). When wand connector 114 and controller connector 120 are coupled, each electrical pin 702 couples to a single electrical pin 602. While FIG. 7 shows only four illustrative electrical pins, in some embodiments as few as two electrical pins and as many as 26 electrical pins may be present in the wand connector 120.


While illustrative wand connector 114 is shown to have the tab 600 and male electrical pins 602, and controller connector 120 is shown to have the slot 700 and female electrical pins 702, in alternative embodiments the wand connector has the female electrical pins and slot, and the controller connector 120 has the tab and male electrical pins, or other combination. In other embodiments, the arrangement of the pins within the connectors may enable only a single orientation for connection of the connectors, and thus the tab and slot arrangement may be omitted. In yet still other embodiments, other mechanical arrangements to ensure the wand connector and controller connector couple in only one orientation may be equivalently used. In the case of a wand with only two electrodes, and which electrodes may be either active or return electrodes as the physical situation dictates, there may be no need to ensure the connectors couple in a particular orientation.



FIG. 8 illustrates a controller 104 in accordance with at least some embodiments. In particular, the controller 104 comprises a processor 800. The processor 800 may be a microcontroller, and therefore the microcontroller may be integral with random access memory (RAM) 802, read-only memory (RAM) 804, digital-to-analog converter (D/A) 806, digital outputs (D/O) 808 and digital inputs (D/I) 810. The processor 800 may further provide one or more externally available peripheral busses, such as a serial bus (e.g., I2C), parallel bus, or other bus and corresponding communication mode. The processor 800 may further be integral with a communication logic 812 to enable the processor 800 to communicate with external devices, as well as internal devices, such as display device 124. Although in some embodiments the controller 104 may implement a microcontroller, in yet other embodiments the processor 800 may be implemented as a standalone central processing unit in combination with individual RAM, ROM, communication, D/A, D/O and D/I devices, as well as communication port hardware for communication to peripheral components.


ROM 804 stores instructions executable by the processor 800. In particular, the ROM 804 may comprise a software program that implements the various embodiments of periodically reducing voltage generator output to change position of the plasma relative to the electrodes of the wand (discussed more below), as well as interfacing with the user by way of the display device 124 and/or the foot pedal assembly 130 (FIG. 1). The RAM 802 may be the working memory for the processor 800, where data may be temporarily stored and from which instructions may be executed. Processor 800 couples to other devices within the controller 104 by way of the D/A converter 806 (e.g., the voltage generator 816), digital outputs 808 (e.g., the voltage generator 816), digital inputs 810 (i.e., push button switches 126, and the foot pedal assembly 130 (FIG. 1)), and other peripheral devices.


Voltage generator 816 generates selectable alternating current (AC) voltages that are applied to the electrodes of the wand 102. In the various embodiments, the voltage generator defines two terminals 824 and 826. In accordance with the various embodiments, the voltage generator generates an alternating current (AC) voltage across the terminals 824 and 826. In at least some embodiments the voltage generator 816 is electrically “floated” from the balance of the supply power in the controller 104, and thus the voltage on terminals 824, 826, when measured with respect to the earth ground or common (e.g., common 828) within the controller 104, may or may not show a voltage difference even when the voltage generator 816 is active.


The voltage generated and applied between the active terminal 824 and return terminal 826 by the voltage generator 816 is a RF signal that, in some embodiments, has a frequency of between about 5 kilo-Hertz (kHz) and 20 Mega-Hertz (MHz), in some cases being between about 30 kHz and 2.5 MHz, often between about 100 kHz and 200 kHz. In applications associated with otolaryngology-head and neck procedures, a frequency of about 100 kHz appears most effective. The RMS (root mean square) voltage generated by the voltage generator 816 may be in the range from about 5 Volts (V) to 1000 V, preferably being in the range from about 10 V to 500 V, often between about 100 V to 350 V depending on the active electrode size and the operating frequency. The peak-to-peak voltage generated by the voltage generator 816 for ablation or cutting in some embodiments is a square wave form in the range of 10 V to 2000 V and in some cases in the range of 100 V to 1800 V and in other cases in the range of about 28 V to 1200 V, often in the range of about 100 V to 320 V peak-to-peak (again, depending on the electrode size and the operating frequency).


Still referring to the voltage generator 816, the voltage generator 816 delivers average power levels ranging from several milliwatts to hundreds of watts per electrode, depending on the voltage applied for the target tissue being treated, and/or the maximum allowed temperature selected for the wand 102. The voltage generator 816 is configured to enable a user to select the voltage level according to the specific requirements of a particular procedure. A description of one suitable voltage generator 816 can be found in commonly assigned U.S. Pat. Nos. 6,142,992 and 6,235,020, the complete disclosure of both patents are incorporated herein by reference for all purposes.


In some embodiments, the various operational modes of the voltage generator 816 may be controlled by way of digital-to-analog converter 806. That is, for example, the processor 800 may control the output voltage by providing a variable voltage to the voltage generator 816, where the voltage provided is proportional to the voltage generated by the voltage generator 816. In other embodiments, the processor 800 may communicate with the voltage generator by way of one or more digital output signals from the digital output 808 device, or by way of packet based communications using the communication device 812 (connection not specifically shown so as not to unduly complicate FIG. 8).



FIG. 8 also shows a simplified side view of the distal end 108 of the wand 102. As shown, illustrative active electrode 202 of the wand 102 electrically couples to terminal 824 of the voltage generator 816 by way of the connector 120, and return electrode 204 electrically couples to terminal 826 of the voltage generator 816.



FIG. 9 shows a method in accordance with at least some embodiments. In particular, the method starts (block 900) and proceeds to: flowing a conductive fluid within a fluid conduit disposed within a electrosurgical wand, the conductive fluid discharges through a discharge aperture and flows through a return electrode disposed distally from the fluid conduit, and is then discharged over an active electrode and a digester electrode recessed away from the active electrode and electrically connected to the active electrode (block 902); applying electrical energy between the active electrode and the return electrode (block 904); forming, responsive to the energy, a localized plasma proximate the active electrode and the digester electrode (block 906); ablating, by the localized plasma, a portion of a target tissue proximate to the active electrode (block 908); and breaking down, responsive to the energy, aspirated fragmented by-products of the ablated portion of the target tissue proximate to the digester electrode (block 910). And thereafter the method ends (block 912).


The above discussion is meant to be illustrative of the principles and various embodiments of the present invention. Numerous variations and modifications possible. For example, while in some cases electrodes were designated as upper electrodes and lower electrodes, such a designation was for purposes of discussion, and shall not be read to require any relationship to gravity during surgical procedures. It is intended that the following claims be interpreted to embrace all such variations and modifications.


While preferred embodiments of this disclosure have been shown and described, modifications thereof can be made by one skilled in the art without departing from the scope or teaching herein. The embodiments described herein are exemplary only and are not limiting. Because many varying and different embodiments may be made within the scope of the present inventive concept, including equivalent structures, materials, or methods hereafter thought of, and because many modifications may be made in the embodiments herein detailed in accordance with the descriptive requirements of the law, it is to be understood that the details herein are to be interpreted as illustrative and not in a limiting sense.

Claims
  • 1. An electrosurgical wand for electrosurgically treating a target tissue comprising: an elongate shaft having a proximal handle end and a distal end;a first active electrode surface disposed on the distal end of the shaft and a first digester electrode surface recessed away from the first active electrode surface and electrically connected with the first active electrode surface; andan aspiration aperture disposed adjacent the first active electrode surface and fluidly connected with an aspiration lumen, wherein the first digester electrode surface is disposed within the aspiration lumen; anda return electrode located proximal to the active electrode comprising a crescent shaped discharge aperture, the crescent shaped aperture comprising a central axis coaxial with a first largest opening portion of the aperture and wherein the central axis is further disposed approximately in line with the first active electrode surface; and wherein the crescent aperture further comprises two narrower opening portions that extend from the central axis, in a lateral and distal direction.
  • 2. The electrosurgical wand of claim 1, wherein the first active electrode surface is disposed substantially across the aspiration aperture.
  • 3. The electrosurgical wand of claim 1, wherein the first active electrode surface and the digester electrode surface are substantially parallel to each other.
  • 4. The electrosurgical wand of claim 1, wherein the digester electrode surface is substantially parallel with a long axis of the aspiration lumen.
  • 5. The electrosurgical wand of claim 1, wherein the digester electrode surface further comprises at least one asperity, operable to readily initiate plasma adjacent said asperity, in the presence of a high frequency voltage and electrically conductive fluids.
  • 6. The electrosurgical wand of claim 1, wherein the return electrode is disposed on the side of the shaft corresponding to the first active electrode surface.
  • 7. The electrosurgical wand of claim 1, wherein the elongate shaft further comprises a medial portion that is proximal to the distal end; the medial portion having a medial axis and the distal end having a tip axis, and wherein the angle between the tip axis and the medial axis is greater than zero.
  • 8. The electrosurgical wand of claim 7, wherein the angle between the tip axis and the medial axis is acute.
  • 9. The electrosurgical wand of claim 7, wherein the proximal handle end comprises a proximal axis and wherein the angle between the proximal axis and the medial axis is greater than zero.
  • 10. The electrosurgical wand of claim 1, wherein the wand is adapted so as to access and treat laryngeal tissue.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims the benefit under 35 U.S.C. §119(e) of U.S. Provisional Application No. 61/448,289 filed Mar. 2, 2011, the complete disclosure of which is incorporated herein by reference for all purposes.

US Referenced Citations (434)
Number Name Date Kind
2050904 Talley Aug 1936 A
2056377 Wappler Oct 1939 A
3633425 Sanford Jan 1972 A
3815604 O'Malley et al. Jun 1974 A
3828780 Morrison, Jr. et al. Aug 1974 A
3901242 Storz Aug 1975 A
3920021 Hiltebrandt Nov 1975 A
3939839 Curtiss Feb 1976 A
3970088 Morrison Jul 1976 A
4033351 Hetzel Jul 1977 A
4040426 Morrison, Jr. Aug 1977 A
4043342 Morrison, Jr. Aug 1977 A
4074718 Morrison, Jr. Feb 1978 A
4092986 Schneiderman Jun 1978 A
4116198 Roos Sep 1978 A
4181131 Ogiu Jan 1980 A
4184492 Meinke et al. Jan 1980 A
4202337 Hren et al. May 1980 A
4228800 Degler, Jr. et al. Oct 1980 A
4232676 Herczog Nov 1980 A
4248231 Herczog et al. Feb 1981 A
4301802 Poler Nov 1981 A
4326529 Doss et al. Apr 1982 A
4381007 Doss Apr 1983 A
4474179 Koch Oct 1984 A
4476862 Pao Oct 1984 A
4532924 Auth et al. Aug 1985 A
4548207 Reimels Oct 1985 A
4567890 Ohta et al. Feb 1986 A
4582057 Auth et al. Apr 1986 A
4590934 Malis et al. May 1986 A
4593691 Lindstrom et al. Jun 1986 A
4658817 Hardy Apr 1987 A
4660571 Hess et al. Apr 1987 A
4674499 Pao Jun 1987 A
4682596 Bales et al. Jul 1987 A
4706667 Roos Nov 1987 A
4709698 Johnston et al. Dec 1987 A
4727874 Bowers et al. Mar 1988 A
4765331 Petruzzi et al. Aug 1988 A
4785823 Eggers et al. Nov 1988 A
4805616 Pao Feb 1989 A
4823791 D'Amelio et al. Apr 1989 A
4832048 Cohen May 1989 A
4860752 Turner Aug 1989 A
4907589 Cosman Mar 1990 A
4920978 Colvin May 1990 A
4931047 Broadwin et al. Jun 1990 A
4936281 Stasz Jun 1990 A
4936301 Rexroth et al. Jun 1990 A
4943290 Rexroth et al. Jul 1990 A
4966597 Cosman Oct 1990 A
4967765 Turner et al. Nov 1990 A
4976711 Parins et al. Dec 1990 A
4979948 Geddes et al. Dec 1990 A
4998933 Eggers et al. Mar 1991 A
5007908 Rydell Apr 1991 A
5009656 Reimels Apr 1991 A
5035696 Rydell Jul 1991 A
5047026 Rydell Sep 1991 A
5047027 Rydell Sep 1991 A
5057105 Malone et al. Oct 1991 A
5057106 Kasevich et al. Oct 1991 A
5078716 Doll Jan 1992 A
5078717 Parins et al. Jan 1992 A
5080660 Buelna Jan 1992 A
5083565 Parins Jan 1992 A
5084044 Quint Jan 1992 A
5085659 Rydell Feb 1992 A
5088997 Delahuerga et al. Feb 1992 A
5098431 Rydell Mar 1992 A
5099840 Goble Mar 1992 A
5102410 Dressel Apr 1992 A
5108391 Flachenecker et al. Apr 1992 A
RE33925 Bales et al. May 1992 E
5112330 Nishigaki et al. May 1992 A
5122138 Manwaring Jun 1992 A
5125928 Parins et al. Jun 1992 A
5156151 Imran Oct 1992 A
5167659 Ohtomo et al. Dec 1992 A
5167660 Altendorf Dec 1992 A
5171311 Rydell et al. Dec 1992 A
5178620 Eggers et al. Jan 1993 A
5190517 Zieve et al. Mar 1993 A
5192280 Parins Mar 1993 A
5195959 Smith Mar 1993 A
5195968 Lundquist et al. Mar 1993 A
5196007 Ellman Mar 1993 A
5197466 Marchosky et al. Mar 1993 A
5197963 Parins Mar 1993 A
5207675 Canady May 1993 A
5217457 Delahuerga et al. Jun 1993 A
5217459 Kamerling Jun 1993 A
5249585 Turner et al. Oct 1993 A
5261410 Alfano et al. Nov 1993 A
5267994 Gentelia et al. Dec 1993 A
5267997 Farin et al. Dec 1993 A
5273524 Fox et al. Dec 1993 A
5277201 Stern Jan 1994 A
5281216 Klicek Jan 1994 A
5281218 Imran Jan 1994 A
5290282 Casscells Mar 1994 A
5300069 Hunsberger et al. Apr 1994 A
5306238 Fleenor Apr 1994 A
5312400 Bales et al. May 1994 A
5314406 Arias et al. May 1994 A
5324254 Phillips Jun 1994 A
5330470 Hagen Jul 1994 A
5334140 Philips Aug 1994 A
5334183 Wuchinich Aug 1994 A
5334193 Nardella Aug 1994 A
5336220 Ryan et al. Aug 1994 A
5336443 Odashima Aug 1994 A
5342357 Nardella Aug 1994 A
5363861 Edwards et al. Nov 1994 A
5366443 Eggers et al. Nov 1994 A
5370675 Edwards et al. Dec 1994 A
5374261 Yoon Dec 1994 A
5375588 Yoon Dec 1994 A
5380277 Phillips Jan 1995 A
5380316 Aita Jan 1995 A
5383876 Nardella Jan 1995 A
5383917 Desai et al. Jan 1995 A
5389096 Aita Feb 1995 A
5395312 Desai Mar 1995 A
5395363 Billings et al. Mar 1995 A
5395368 Ellman et al. Mar 1995 A
5400267 Denen et al. Mar 1995 A
5401272 Perkins Mar 1995 A
5403311 Abele et al. Apr 1995 A
5417687 Nardella et al. May 1995 A
5419767 Eggers et al. May 1995 A
5423810 Goble et al. Jun 1995 A
5423811 Imran et al. Jun 1995 A
5423812 Ellman et al. Jun 1995 A
5423882 Jackman et al. Jun 1995 A
5436566 Thompson et al. Jul 1995 A
5437662 Nardella Aug 1995 A
5438302 Goble Aug 1995 A
5441499 Fritzsch Aug 1995 A
5451224 Goble et al. Sep 1995 A
5454809 Janssen Oct 1995 A
5456662 Edwards et al. Oct 1995 A
5458596 Lax et al. Oct 1995 A
5487757 Truckai et al. Jan 1996 A
5490850 Ellman et al. Feb 1996 A
5496312 Klicek Mar 1996 A
5496314 Eggers Mar 1996 A
5496317 Goble et al. Mar 1996 A
5505728 Ellman et al. Apr 1996 A
5505730 Edwards Apr 1996 A
5514130 Baker May 1996 A
5554152 Aita Sep 1996 A
5556397 Long et al. Sep 1996 A
5562503 Ellman et al. Oct 1996 A
5562703 Desai Oct 1996 A
5569242 Lax et al. Oct 1996 A
5571100 Goble et al. Nov 1996 A
5571101 Ellman et al. Nov 1996 A
5584872 LaFontaine et al. Dec 1996 A
5609151 Mulier et al. Mar 1997 A
5624439 Edwards et al. Apr 1997 A
5630812 Ellman et al. May 1997 A
5633578 Eggers et al. May 1997 A
5647869 Goble et al. Jul 1997 A
5658278 Imran et al. Aug 1997 A
5662680 Desai Sep 1997 A
5674191 Edwards et al. Oct 1997 A
5676693 LaFontaine et al. Oct 1997 A
5681282 Eggers et al. Oct 1997 A
5683366 Eggers et al. Nov 1997 A
5683386 Ellman et al. Nov 1997 A
5683387 Garito et al. Nov 1997 A
5688267 Panescu et al. Nov 1997 A
5695495 Ellman et al. Dec 1997 A
5697281 Eggers et al. Dec 1997 A
5697536 Eggers et al. Dec 1997 A
5697882 Eggers et al. Dec 1997 A
5697909 Eggers et al. Dec 1997 A
5700262 Acosta et al. Dec 1997 A
5707349 Edwards Jan 1998 A
5718702 Edwards Feb 1998 A
5725524 Mulier et al. Mar 1998 A
5728094 Edwards Mar 1998 A
5733282 Ellman et al. Mar 1998 A
5738114 Edwards Apr 1998 A
5743870 Edwards Apr 1998 A
5746224 Edwards May 1998 A
5749869 Lindenmeier et al. May 1998 A
5766153 Eggers et al. Jun 1998 A
5775338 Hastings Jul 1998 A
5776128 Eggers Jul 1998 A
5782828 Chen et al. Jul 1998 A
5800379 Edwards Sep 1998 A
5800429 Edwards Sep 1998 A
5807395 Mulier et al. Sep 1998 A
5810764 Eggers et al. Sep 1998 A
5810809 Rydell Sep 1998 A
5817049 Edwards Oct 1998 A
5820580 Edwards et al. Oct 1998 A
5823197 Edwards Oct 1998 A
5827277 Edwards Oct 1998 A
5836875 Webster, Jr. Nov 1998 A
5843019 Eggers et al. Dec 1998 A
5843021 Edwards et al. Dec 1998 A
5843077 Edwards Dec 1998 A
5860951 Eggers Jan 1999 A
5860974 Abele Jan 1999 A
5860975 Goble et al. Jan 1999 A
5871469 Eggers et al. Feb 1999 A
5873855 Eggers et al. Feb 1999 A
5879349 Edwards Mar 1999 A
5885277 Korth Mar 1999 A
5888198 Eggers et al. Mar 1999 A
5891095 Eggers et al. Apr 1999 A
5891134 Goble et al. Apr 1999 A
5897553 Mulier Apr 1999 A
5902272 Eggers et al. May 1999 A
5916214 Cosio et al. Jun 1999 A
5919190 Vandusseldorp Jul 1999 A
5921983 Shannon, Jr. Jul 1999 A
5944715 Goble et al. Aug 1999 A
5954716 Sharkey et al. Sep 1999 A
5988171 Sohn et al. Nov 1999 A
6004319 Goble et al. Dec 1999 A
6006755 Edwards Dec 1999 A
6009877 Edwards Jan 2000 A
6013076 Goble et al. Jan 2000 A
6015406 Goble et al. Jan 2000 A
6024733 Eggers et al. Feb 2000 A
6026816 McMillan et al. Feb 2000 A
6027501 Goble et al. Feb 2000 A
6032674 Eggers et al. Mar 2000 A
6039734 Goble et al. Mar 2000 A
6044846 Edwards Apr 2000 A
6047700 Eggers et al. Apr 2000 A
6056746 Goble et al. May 2000 A
6063079 Hovda et al. May 2000 A
6066134 Eggers et al. May 2000 A
6066139 Ryan et al. May 2000 A
6068628 Fanton et al. May 2000 A
6071281 Burnside et al. Jun 2000 A
6073052 Zelickson et al. Jun 2000 A
6074386 Goble et al. Jun 2000 A
6086585 Hovda et al. Jul 2000 A
6090106 Goble et al. Jul 2000 A
6093186 Goble et al. Jul 2000 A
6102046 Weinstein et al. Aug 2000 A
6105581 Eggers et al. Aug 2000 A
6109268 Thapliyal et al. Aug 2000 A
6117109 Eggers et al. Sep 2000 A
6126682 Sharkey et al. Oct 2000 A
6142992 Cheng et al. Nov 2000 A
6149620 Baker et al. Nov 2000 A
6159194 Eggers et al. Dec 2000 A
6159208 Hovda et al. Dec 2000 A
6168593 Sharkey et al. Jan 2001 B1
6174309 Wrublewski et al. Jan 2001 B1
6179824 Eggers et al. Jan 2001 B1
6179836 Eggers et al. Jan 2001 B1
6183469 Thapliyal et al. Feb 2001 B1
6190381 Olsen et al. Feb 2001 B1
6203542 Ellsberry et al. Mar 2001 B1
6210402 Olsen et al. Apr 2001 B1
6210405 Goble et al. Apr 2001 B1
6224592 Eggers et al. May 2001 B1
6228078 Eggers May 2001 B1
6228081 Goble May 2001 B1
6234178 Goble et al. May 2001 B1
6235020 Cheng et al. May 2001 B1
6237604 Burnside et al. May 2001 B1
6238391 Olsen et al. May 2001 B1
6254600 Willink et al. Jul 2001 B1
6258086 Ashley et al. Jul 2001 B1
6261286 Goble et al. Jul 2001 B1
6261311 Sharkey et al. Jul 2001 B1
6264652 Eggers et al. Jul 2001 B1
6270460 McCartan et al. Aug 2001 B1
6270476 Santoianni et al. Aug 2001 B1
6277112 Underwood et al. Aug 2001 B1
6280441 Ryan Aug 2001 B1
6283961 Underwood et al. Sep 2001 B1
6293942 Goble et al. Sep 2001 B1
6296636 Cheng et al. Oct 2001 B1
6296638 Davison et al. Oct 2001 B1
6306134 Goble et al. Oct 2001 B1
6308089 von der Rur et al. Oct 2001 B1
6309387 Eggers et al. Oct 2001 B1
6312408 Eggers et al. Nov 2001 B1
6322549 Eggers et al. Nov 2001 B1
6355032 Hovda et al. Mar 2002 B1
6363937 Hovda et al. Apr 2002 B1
6364877 Goble et al. Apr 2002 B1
6379350 Sharkey et al. Apr 2002 B1
6379351 Thapliyal et al. Apr 2002 B1
6387093 Ellman et al. May 2002 B1
6391025 Weinstein et al. May 2002 B1
6411852 Danek et al. Jun 2002 B1
6413254 Hissong et al. Jul 2002 B1
6416491 Edwards et al. Jul 2002 B1
6416507 Eggers et al. Jul 2002 B1
6416508 Eggers et al. Jul 2002 B1
6416509 Goble et al. Jul 2002 B1
6427089 Knowlton Jul 2002 B1
6432103 Ellsberry et al. Aug 2002 B1
6464699 Swanson Oct 2002 B1
6468274 Alleyne et al. Oct 2002 B1
6468275 Wampler et al. Oct 2002 B1
6482201 Olsen et al. Nov 2002 B1
6491690 Goble et al. Dec 2002 B1
6517498 Burbank et al. Feb 2003 B1
6530922 Cosman Mar 2003 B2
6530924 Ellman et al. Mar 2003 B1
6551032 Nolan et al. Apr 2003 B1
6572613 Ellman et al. Jun 2003 B1
6578579 Burnside Jun 2003 B2
6589235 Wong et al. Jul 2003 B2
6589237 Woloszko et al. Jul 2003 B2
6602248 Sharps et al. Aug 2003 B1
6620156 Garito et al. Sep 2003 B1
6632193 Davison et al. Oct 2003 B1
6632220 Eggers et al. Oct 2003 B1
6702810 McClurken et al. Mar 2004 B2
6736810 Hoey et al. May 2004 B2
6746447 Davison et al. Jun 2004 B2
6749604 Eggers et al. Jun 2004 B1
6749608 Garito et al. Jun 2004 B2
6770071 Woloszko et al. Aug 2004 B2
6780178 Palanker et al. Aug 2004 B2
6780180 Goble et al. Aug 2004 B1
6802842 Ellman et al. Oct 2004 B2
6837887 Woloszko et al. Jan 2005 B2
6837888 Ciarrocca et al. Jan 2005 B2
6896674 Woloszko et al. May 2005 B1
6920883 Bessette et al. Jul 2005 B2
6929640 Underwood et al. Aug 2005 B1
6942662 Goble et al. Sep 2005 B2
6949096 Davison et al. Sep 2005 B2
6955172 Nelson et al. Oct 2005 B2
6960204 Eggers et al. Nov 2005 B2
6974453 Woloszko et al. Dec 2005 B2
6984231 Goble et al. Jan 2006 B2
6991631 Woloszko et al. Jan 2006 B2
7004941 Tvinnereim et al. Feb 2006 B2
7041102 Truckai et al. May 2006 B2
7066936 Ryan Jun 2006 B2
7070596 Woloszko et al. Jul 2006 B1
7090672 Underwood et al. Aug 2006 B2
7094215 Davison et al. Aug 2006 B2
7104986 Hovda et al. Sep 2006 B2
7131969 Hovda et al. Nov 2006 B1
7160296 Pearson et al. Jan 2007 B2
7169143 Eggers et al. Jan 2007 B2
7179255 Lettice et al. Feb 2007 B2
7186234 Dahla et al. Mar 2007 B2
7192428 Eggers et al. Mar 2007 B2
7195630 Ciarrocca Mar 2007 B2
7201750 Eggers et al. Apr 2007 B1
7217268 Eggers et al. May 2007 B2
7241293 Davison Jul 2007 B2
7270658 Woloszko et al. Sep 2007 B2
7270659 Ricart et al. Sep 2007 B2
7270661 Dahla et al. Sep 2007 B2
7276063 Davison et al. Oct 2007 B2
7297143 Woloszko et al. Nov 2007 B2
7297145 Woloszko et al. Nov 2007 B2
7318823 Sharps et al. Jan 2008 B2
7331956 Hovda et al. Feb 2008 B2
RE40156 Sharps et al. Mar 2008 E
7357798 Sharps et al. Apr 2008 B2
7387625 Hovda et al. Jun 2008 B2
7419488 Ciarrocca et al. Sep 2008 B2
7429260 Underwood et al. Sep 2008 B2
7429262 Woloszko et al. Sep 2008 B2
7435247 Woloszko et al. Oct 2008 B2
7442191 Hovda et al. Oct 2008 B2
7445618 Eggers et al. Nov 2008 B2
7449021 Underwood et al. Nov 2008 B2
7462178 Woloszko et al. Dec 2008 B2
7468059 Eggers et al. Dec 2008 B2
7491200 Underwood et al. Feb 2009 B2
7507236 Eggers et al. Mar 2009 B2
7572251 Davison et al. Aug 2009 B1
7632267 Dahla Dec 2009 B2
7691101 Davison et al. Apr 2010 B2
7704249 Woloszko et al. Apr 2010 B2
7708733 Sanders et al. May 2010 B2
7824398 Woloszko et al. Nov 2010 B2
7879034 Woloszko et al. Feb 2011 B2
7892230 Woloszko et al. Feb 2011 B2
7901403 Woloszko et al. Mar 2011 B2
8012153 Woloszko et al. Sep 2011 B2
8114071 Woloszko et al. Feb 2012 B2
8568405 Cox et al. Oct 2013 B2
8747401 Gonzalez et al. Jun 2014 B2
20020026186 Woloszko et al. Feb 2002 A1
20020029036 Goble et al. Mar 2002 A1
20020049438 Sharkey et al. Apr 2002 A1
20030013986 Saadat Jan 2003 A1
20030014050 Sharkey et al. Jan 2003 A1
20030088245 Woloszko et al. May 2003 A1
20030097129 Davison et al. May 2003 A1
20030158545 Hovda et al. Aug 2003 A1
20030171743 Tasto et al. Sep 2003 A1
20030208196 Stone Nov 2003 A1
20030212396 Eggers et al. Nov 2003 A1
20040054366 Davison et al. Mar 2004 A1
20040116922 Hovda et al. Jun 2004 A1
20040127893 Hovda Jul 2004 A1
20040230190 Dahla et al. Nov 2004 A1
20050004634 Ricart et al. Jan 2005 A1
20050043728 Ciarrocca Feb 2005 A1
20050261754 Woloszko et al. Nov 2005 A1
20050283149 Thorne et al. Dec 2005 A1
20050288665 Woloszko Dec 2005 A1
20060036237 Davison et al. Feb 2006 A1
20060095031 Ormsby May 2006 A1
20060189971 Tasto et al. Aug 2006 A1
20060253117 Hovda et al. Nov 2006 A1
20060259025 Dahla Nov 2006 A1
20060259031 Carmel et al. Nov 2006 A1
20070106288 Woloszko et al. May 2007 A1
20070149966 Dahla et al. Jun 2007 A1
20070161981 Sanders et al. Jul 2007 A1
20070208335 Woloszko et al. Sep 2007 A1
20080200972 Rittman et al. Aug 2008 A1
20100137859 Wang Jun 2010 A1
20100204690 Bigley et al. Aug 2010 A1
20120101494 Cadouri et al. Apr 2012 A1
20120191089 Gonzalez et al. Jul 2012 A1
20120203219 Evans et al. Aug 2012 A1
20130066317 Evans et al. Mar 2013 A1
20130197506 Evans et al. Aug 2013 A1
20140200581 Aluru et al. Jul 2014 A1
Foreign Referenced Citations (79)
Number Date Country
3930451 Mar 1991 DE
202014002299.20 Jul 2014 DE
0509670 Oct 1992 EP
0703461 Mar 1996 EP
0740926 Nov 1996 EP
0754437 Jan 1997 EP
0694290 Nov 2000 EP
2198799 Jun 2010 EP
2313949 Jan 1977 FR
2 308 979 Jul 1997 GB
2 308 980 Jul 1997 GB
2 308 981 Jul 1997 GB
2 327 350 Jan 1999 GB
2 327 351 Jan 1999 GB
2 327 352 Jan 1999 GB
2479582 Oct 2011 GB
57-57802 Apr 1982 JP
57-117843 Jul 1982 JP
58-13213 Jan 1983 JP
10-43198 Feb 1998 JP
9003152 Apr 1990 WO
9007303 Jul 1990 WO
9221278 Dec 1992 WO
9313816 Jul 1993 WO
9320747 Oct 1993 WO
9404220 Mar 1994 WO
9408654 Apr 1994 WO
9410924 May 1994 WO
9426228 Nov 1994 WO
9534259 Dec 1995 WO
9600042 Jan 1996 WO
9623449 Aug 1996 WO
9637156 Nov 1996 WO
9639914 Dec 1996 WO
9700646 Jan 1997 WO
9700647 Jan 1997 WO
9715237 May 1997 WO
9718765 May 1997 WO
9724073 Jul 1997 WO
9724074 Jul 1997 WO
9724993 Jul 1997 WO
9724994 Jul 1997 WO
9730644 Aug 1997 WO
9730645 Aug 1997 WO
9730646 Aug 1997 WO
9730647 Aug 1997 WO
9741785 Nov 1997 WO
9741786 Nov 1997 WO
9741787 Nov 1997 WO
9741788 Nov 1997 WO
9743969 Nov 1997 WO
9743970 Nov 1997 WO
9743972 Nov 1997 WO
9743973 Nov 1997 WO
9744092 Nov 1997 WO
9748345 Dec 1997 WO
9748346 Dec 1997 WO
9803117 Jan 1998 WO
9807468 Feb 1998 WO
9827879 Jul 1998 WO
9827880 Jul 1998 WO
9908613 Feb 1999 WO
9909919 Mar 1999 WO
9917690 Apr 1999 WO
9930655 Jun 1999 WO
9951155 Oct 1999 WO
9951158 Oct 1999 WO
0062698 Oct 2000 WO
0187154 May 2001 WO
0236028 May 2002 WO
02085230 Oct 2002 WO
03005882 Jan 2003 WO
03024305 Mar 2003 WO
03047446 Jun 2003 WO
03068095 Aug 2003 WO
2004050171 Jun 2004 WO
2005125287 Dec 2005 WO
2006002337 Jan 2006 WO
2006125007 Nov 2006 WO
Non-Patent Literature Citations (93)
Entry
Barry et al., “The Effect of Radiofrequency-generated Thermal Energy on the Mechanical and Histologic Characteristics of the Arterial Wall in Vivo: Implications of Radiofrequency Angioplasty” American Heart Journal vol. 117, pp. 332-341, 1982.
BiLAP Generator Settings, Jun. 1991.
BiLAP IFU 910026-001 Rev A for BiLAP Model 3525, J-Hook, 4 pgs, May 20, 1991.
BiLAP IFU 910033-002 Rev A for BiLAP Model 3527, L-Hook; BiLAP Model 3525, J-Hook; BiLAP Model 3529, High Angle, 2 pgs, Nov. 30, 1993.
Codman & Shurtleff, Inc. “The Malis Bipolar Coagulating and Bipolar Cutting System CMC—II” brochure, early, 2 pgs, 1991.
Codman & Shurtleff, Inc. “The Malis Bipolar Electrosurgical System CMC—III Instruction Manual”, 15 pgs, Jul. 1991.
Cook et al., “Therapeutic Medical Devices: Application and Design”, Prentice Hall, Inc., 3pgs, 1982.
Dennis et al. “Evolution of Electrofulguration in Control of Bleeding of Experimental Gastric Ulcers,” Digestive Diseases and Sciences, vol. 24, No. 11, 845-848, Nov. 1979.
Dobbie, A.K., “The Electrical Aspects of Surgical Diathermy, Bio Medical Engineering” Bio-Medical Engineering vol. 4, pp. 206-216, May 1969.
Elsasser, V.E. et al., “An Instrument for Transurethral Resection without Leakage of Current” Acta Medicotechnica vol. 24, No. 4, pp. 129-134, 1976.
Geddes, “Medical Device Accidents: With Illustrative Cases” CRC Press, 3 pgs, 1998.
Honig, W., “The Mechanism of Cutting in Electrosurgery” IEEE pp. 58-65, 1975.
Kramolowsky et al. “The Urological App of Electorsurgery” J. of Urology vol. 146, pp. 669-674, 1991.
Kramolowsky et al. “Use of 5F Bipolar Electrosurgical Probe in Endoscopic Urological Procedures” J. of Urology vol. 143, pp. 275-277, 1990.
Lee, B et al. “Thermal Compression and Molding of Artherosclerotic Vascular Tissue with Use” JACC vol. 13(5), pp. 1167-1171, 1989.
Letter from Department of Health to Jerry Malis dated Jan. 24, 1991, 3 pgs.
Letter from Department of Health to Jerry Malis dated Jul. 25, 1985, 1 pg.
Letter from Jerry Malis to FDA dated Jul. 25, 1985, 2 pgs.
Lu, et al., “Electrical Thermal Angioplasty: Catheter Design Features, In Vitro Tissue Ablation Studies and In Vitro Experimental Findings,” Am J. Cardiol vol. 60, pp. 1117-1122, Nov. 1, 1987.
Malis, L., “Electrosurgery, Technical Note,” J. Neursurg., vol. 85, pp. 970-975, Nov. 1996.
Malis, L., “Excerpted from a seminar by Leonard I. Malis, M.D. at the 1995 American Association of Neurological Surgeons Meeting,” 1pg, 1995.
Malis, L., “Instrumentation for Microvascular Neurosurgery” Cerebrovascular Surgery, vol. 1, pp. 245-260, 1985.
Malis, L., “New Trends in Microsurgery and Applied Technology,” Advanced Technology in Neurosurgery, pp. 1-16, 1988.
Malis, L., “The Value of Irrigation During Bipolar Coagulation” See ARTC 21602, 1 pg, Apr. 9, 1993.
Nardella, P.C., SPIE 1068: pp. 42-49, Radio Frequency Energy and Impedance Feedback, 1989.
O'Malley, Schaum's Outline of Theory and Problems of Basic Circuit Analysis, McGraw-Hill, 2nd Ed., pp. 3-5, 1992.
Olsen MD, Bipolar Laparoscopic Cholecstectomy Lecture (marked confidential), 12 pgs, Oct. 7, 1991.
Pearce, John A. “Electrosurgery”, pp. 17, 69-75, 87, John Wiley & Sons, New York, 1986.
Pearce, John A., “Electrosurgery”, Handbook of Biomedical Engineering, chapter 3, Academic Press Inc., N.Y., pp. 98-113, 1988.
Piercey et al., “Electrosurgical Treatment of Experimental Bleeding Canine Gastric Ulcers” Gastroenterology vol. 74(3), pp. 527-534, 1978.
Protell et al., “Computer-Assisted Electrocoagulation: Bipolar v. Monopolar in the Treatment of Experimental Canine Gastric Ulcer Bleeding,” Gastroenterology vol. 80, No. 3, pp. 451-455, 1981.
Ramsey et al., “A Comparison of Bipolar and Monopolar Diathermy Probes in Experimental Animals”, Urological Research vol. 13, pp. 99-102, 1985.
Selikowitz et al., “Electric Current and Voltage Recordings on the Myocardium During Electrosurgical Procedures in Canines,” Surgery, Gynecology & Obstetrics, vol. 164, pp. 219-224, Mar. 1987.
Shuman, “Bipolar Versus Monopolar Electrosurgery: Clinical Applications,” Dentistry Today, vol. 20, No. 12, 7 pgs, Dec. 2001.
Slager et al. “Spark Erosion of Arteriosclerotic Plaques” Z. Kardiol. 76:Suppl. 6, pp. 67-71, 1987.
Slager et al. “Vaporization of Atherosclerotice Plaques by Spark Erosion” JACC 5(6): pp. 1382-1386, Jun. 1985.
Stoffels, E. et al., “Investigation on the Interaction Plasma-Bone Tissue”, E-MRS Spring Meeting, 1 pg, Jun. 18-21, 2002.
Stoffels, E. et al., “Biomedical Applications of Plasmas”, Tutorial presented prior to the 55th Gaseous Electronics Conference in Minneapolis, MN, 41 pgs, Oct. 14, 2002.
Stoffels, E. et al., “Plasma Interactions with Living Cells”, Eindhoven University of Technology, 1 pg, 2002.
Stoffels, E. et al., “Superficial Treatment of Mammalian Cells using Plasma Needle”, J. Phys. D: Appl. Phys. 26, pp. 2908-2913, Nov. 19, 2003.
Stoffels, E. et al., “Plasma Needle”, Eindhoven University of Technology, 1 pg, Nov. 28, 2003.
Stoffels, E. et al., “Plasma Physicists Move into Medicine”, Physicsweb, 1 pg, Nov. 2003.
Stoffels, E. et al., “Plasma Treated Tissue Engineered Skin to Study Skin Damage”, Biomechanics and Tissue Engineering, Materials Technology, 1 pg, 2003.
Stoffels, E. et al., “Plasma Treatment of Dental Cavities: A Feasibility Study”, IEEE Transaction on Plasma Science, vol. 32, No. 4, pp. 1540-1542, Aug. 2004.
Stoffels, E. et al., “The Effects of UV Irradiation and Gas Plasma Treatment on Living Mammalian Cells and Bacteria: A Comparative Approach”, IEEE Transaction on Plasma Science, vol. 32, No. 4, pp. 1544-1550, Aug. 2004.
Stoffels, E. et al., “Electrical and Optical Characterization of the Plasma Needle”, New Journal of Physics 6, pp. 1-14, Oct. 28, 2004.
Stoffels, E. et al., “Where Plasma Meets Plasma”, Eindhoven University of Technology, 23 pgs, 2004.
Stoffels, E. et al., “Gas Plasma effects on Living Cells”, Physica Scripta, T107, pp. 79-82, 2004.
Stoffels, E. et al., “Plasma Treatment of Mammalian Vascular Cells: A Quantitative Description”, IEEE Transaction on Plasma Science, vol. 33, No. 2, pp. 771-775, Apr. 2005.
Stoffels, E. et al., “Deactivation of Escherichia coli by the Plasma Needle”, J. Phys. D: Appl. Phys. 38, pp. 1716-1721, May 20, 2005.
Stoffels, E. et al., “Development of a Gas Plasma Catheter for Gas Plasma Surgery”, XXVIIth ICPIG, Endoven University of Technology, pp. 18-22, Jul. 2005.
Stoffels, E. et al., “Development of a Smart Positioning Sensor for the Plasma Needle”, Plasma Sources Sci. Technol. 15, pp. 582-589, Jun. 27, 2006.
Stoffels, E. et al., Killing of S. mutans Bacteria Using a Plasma Needle at Atmospheric Pressure, IEEE Transaction on Plasma Science, vol. 34, No. 4, pp. 1317-1324, Aug. 2006.
Stoffels, E. et al., “Plasma-Needle Treatment of Substrates with Respect to Wettability and Growth of Excherichia coli and Streptococcus mutans”, IEEE Transaction on Plasma Science, vol. 34, No. 4, pp. 1325-1330, Aug. 2006.
Stoffels, E. et al., “Reattachment and Apoptosis after Plasma-Needle Treatment of Cultured Cells”, IEEE Transaction on Plasma Science, vol. 34, No. 4, pp. 1331-1336, Aug. 2006.
Stoffels, E. et al., “UV Excimer Lamp Irradiation of Fibroblasts: The Influence on Antioxidant Homostasis”, IEEE Transaction on Plasma Science, vol. 34, No. 4, pp. 1359-1364, Aug. 2006.
Stoffels, E. et al., “Plasma Needle for In Vivo Medical Treatment: Recent Developments and Perspectives”, Plasma Sources Sci. Technol. 15, pp. S169-S180, Oct. 6, 2006.
Swain, C.P., et al., “Which Electrode, A Comparison of four endoscopic methods of electrocoagulation in experimental bleeding ulcers” Gut vol. 25, pp. 1424-1431, 1987.
Tucker, R. et al., Abstract P14-11, p. 248, “A Bipolar Electrosurgical Turp Loop”, Nov. 1989.
Tucker, R. et al. “A Comparison of Urologic Application of Bipolar Versus Monopolar Five French Electrosurgical Probes” J. of Urology vol. 141, pp. 662-665, 1989.
Tucker, R. et al. “In vivo effect of 5 French Bipolar and Monopolar Electrosurgical Probes on the Porcine Bladder” Urological Research vol. 18, pp. 291-294, 1990.
Tucker, R. et al., “Demodulated Low Frequency Currents from Electrosurgical Procedures,” Surgery, Gynecology and Obstetrics, 159:39-43, 1984.
Tucker et al. “The interaction between electrosurgical generators, endoscopic electrodes, and tissue,” Gastrointestinal Endoscopy, vol. 38, No. 2, pp. 118-122, 1992.
Valley Forge Scientific Corp., “Summary of Safety and Effective Information from 510K”, 2pgs, 1991.
Valley Forge's New Products, CLINICA, 475, 5, Nov. 6, 1991.
Valleylab SSE2L Instruction Manual, 11 pgs, Jan. 6, 1983.
Valleylab, Inc. “Valleylab Part No. 945 100 102 A” Surgistat Service Manual, pp. 1-46, Jul. 1988.
Wattiez, Arnaud et al., “Electrosurgery in Operative Endoscopy,” Electrosurgical Effects, Blackwell Science, pp. 85-93, 1995.
Wyeth, “Electrosurgical Unit” pp. 1181-1202, 2000.
Rand et al., “Effect of Elecctrocautery on Fresh Human Articular Cartilage”, J. Arthro. Surg., vol. 1, pp. 242-246, 1985.
European Search Report for EP00123324.6 4 pgs, Mailed Jan. 16, 2001.
European Search Report for EP00928246 4 pgs, Mailed Mar. 7, 2008.
European Search Report for EP09153983 9 pgs, Mailed Apr. 1, 2009.
European Search Report for EP98964730.0 3 pgs, Mailed Nov. 20, 2000.
European Search Report for EP99922855.4 3 pgs, Aug. 2, 2001.
European Search Report for EP05762588 3 pgs, Apr. 12, 2010.
European Search Report for EP06760025.4 5 pgs, Nov. 10, 2010.
PCT International Preliminary Examination Report for PCT/US00/10674 4pgs, Mailed Mar. 7, 2001.
PCT International Preliminary Examination Report for PCT/US98/26624 4pgs, Mailed Oct. 12, 1999.
PCT International Preliminary Examination Report for PCT/US99/10062 3pgs, Jun. 20, 2000.
PCT International Preliminary Report on Patentability for PCT/US05/22373 4pgs, Dec. 28, 2006.
PCT International Preliminary Report on Patentability for PCT/US06/19095 6pgs, Nov. 20, 2007.
PCT International Search Report for PCT/US00/10674 1 pg, Mailed Jul. 27, 2000.
PCT International Search Report for PCT/US03/38782 1 pg, Mailed Jun. 30, 2004.
PCT International Search Report for PCT/US05/22373 1 pg, Mailed Oct. 3, 2006.
PCT International Search Report for PCT/US06/19095 2 pgs, Mailed Oct. 4, 2007.
PCT International Search Report for PCT/US96/08077 1 page, Mailed Sep. 16, 1996.
PCT International Search Report for PCT/US98/26624 1 page, Mailed Mar. 3, 1999.
PCT International Search Report for PCT/US99/10062 1 pg, Mailed Aug. 23, 1999.
UK Search Report for GB1111622.5 4pgs, Mailed Oct. 26, 2011.
UK Search Report for GB1202275.2 7pgs, May 11, 2012.
UK Search Report for GB1202275.2 5pgs, Sep. 12, 2014.
UK Combined Search and Exam Report for GB1404394.7 6pgs, Sep. 17, 2014.
Related Publications (1)
Number Date Country
20120226273 A1 Sep 2012 US
Provisional Applications (1)
Number Date Country
61448289 Mar 2011 US